Singapore - English - HSA (Health Sciences Authority)

msd pharma (singapore) pte. ltd. - (desloratadine coated granules): desloratadine, micronized - tablet, orally disintegrating - 2.5mg - (desloratadine coated granules): desloratadine, micronized 2.5mg

Singapore - English - HSA (Health Sciences Authority)

msd pharma (singapore) pte. ltd. - (desloratadine coated granules):desloratadine, micronized - tablet, orally disintegrating - 5mg - (desloratadine coated granules):desloratadine, micronized 5mg

Canada - English - Health Canada

pharmascience inc - desloratadine - tablet - 5mg - desloratadine 5mg - second generation antihistamines

United States - English - NLM (National Library of Medicine)

organon llc - desloratadine (unii: fvf865388r) (desloratadine - unii:fvf865388r), pseudoephedrine sulfate (unii: y9dl7qpe6b) (pseudoephedrine - unii:7cuc9ddi9f) - clarinex-d® 12 hour extended release tablets is indicated for the relief of the nasal and non-nasal symptoms of seasonal allergic rhinitis, including nasal congestion, in adults and adolescents 12 years of age and older. clarinex-d 12 hour extended release tablets should be administered when the antihistaminic properties of desloratadine and the nasal decongestant properties of pseudoephedrine are desired [see clinical pharmacology (12)]. clarinex-d 12 hour extended release tablets are contraindicated in: - patients with hypersensitivity to any of its ingredients, or to loratadine [see warnings and precautions (5.4) and adverse reactions (6.2)] - patients with narrow-angle glaucoma - patients with urinary retention - patients receiving monoamine oxidase (mao) inhibitor therapy or within fourteen (14) days of stopping such treatment [see drug interactions (7.1)] - patients with severe hypertension or severe coronary artery disease risk summary the limited available data with clarinex-d 12 hour in pregnant wom

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - desloratadine, quantity: 5 mg - tablet, film coated - excipient ingredients: lactose monohydrate; pregelatinised starch; microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; hydrogenated cottonseed oil; dibasic sodium phosphate; maize starch; titanium dioxide; purified talc; xanthan gum; polyvinyl alcohol; lecithin; indigo carmine aluminium lake - the rapid relief of symptoms associated with seasonal allergic rhinitis. the nasal symptoms of allergic rhinits include rhinorrhoea, sneezing and nasal itching. allergic rhinitis is also associated with non-nasal symptoms such as ocular itching, tearing and itching of the eyes or palate. the relief of symptoms associated with perennial allergic rhinitis. the symptomatic relief of itching and reduction in the size and number of hives associated with chronic idiopathic urticaria.

Australia - English - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - desloratadine, quantity: 5 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; hypromellose; pregelatinised starch; purified water; lactose; hydrogenated vegetable oil; microcrystalline cellulose; titanium dioxide; macrogol 400; indigo carmine aluminium lake - the rapid relief of symptoms associated with seasonal allergic rhinitis. the nasal symptoms of allergic rhinitis include rhinorrhoea, sneezing and nasal itching. allergic rhinitis is also associated with non-nasal symptoms such as ocular itching, tearing and itching of the eyes or palate.,the relief of symptoms associated with perennial allergic rhinitis.,the symptomatic relief of itching and reduction in the size and number of hives associated with chronic idiopathic urticaria.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - desloratadine, quantity: 5 mg - tablet, film coated - excipient ingredients: dibasic sodium phosphate; lactose monohydrate; pregelatinised starch; magnesium stearate; maize starch; colloidal anhydrous silica; microcrystalline cellulose; hydrogenated cottonseed oil; titanium dioxide; purified talc; xanthan gum; polyvinyl alcohol; lecithin; indigo carmine aluminium lake - the rapid relief of symptoms associated with seasonal allergic rhinitis. the nasal symptoms of allergic rhinits include rhinorrhoea, sneezing and nasal itching. allergic rhinitis is also associated with non-nasal symptoms such as ocular itching, tearing and itching of the eyes or palate. the relief of symptoms associated with perennial allergic rhinitis. the symptomatic relief of itching and reduction in the size and number of hives associated with chronic idiopathic urticaria.

United States - English - NLM (National Library of Medicine)

a-s medication solutions - desloratadine (unii: fvf865388r) (desloratadine - unii:fvf865388r) - desloratadine tablets are indicated for the relief of the nasal and non-nasal symptoms of seasonal allergic rhinitis in patients 12 years of age and older. desloratadine tablets are indicated for the relief of the nasal and non-nasal symptoms of perennial allergic rhinitis in patients 12 years of age and older. desloratadine tablets are contraindicated in patients who are hypersensitive to this medication or to any of its ingredients or to loratadine [see warnings and precautions (5.1) and adverse reactions (6.2)]. risk summary   the limited available data with desloratadine in pregnant women are not sufficient to inform a drug-associated risk for major birth defects and miscarriage. there are no adequate and well-controlled studies in pregnant women. desloratadine given during organogenesis to pregnant rats was not teratogenic at the summed area under the concentration-time curve (auc)-based exposures of desloratadine and its metabolite approximately 320 times that at the recommended human daily oral dose (r

European Union - English - EMA (European Medicines Agency)

n.v. organon - desloratadine, pseudophedrine sulfate - rhinitis, allergic, seasonal - nasal preparations - symptomatic treatment of seasonal allergic rhinitis when accompanied by nasal congestion.

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

healol pharmaceuticals sdn. bhd. - desloratadine -